Company: INKT
Filing Date: 2025-05-15
Form Type: 8-K
Source: 0001171843-25-003207
Chunk: 1

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-05-15
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibit

The following exhibit is furnished herewith:

  99.1      Press Release dated May 15, 2025                                             
 ─────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  MiNK Therapeutics, Inc.                                   
  By:                          /s/ Christine M. Klaskin     
                               Christine M. Klaskin         
                               Principal Financial Officer